AnteoTech Ltd (ASX:ADO) is a biotechnology company that focuses on developing innovative diagnostics solutions. The company’s core activities include the development of technologies to detect and measure biomarkers in a range of diseases, including cancer, infectious diseases and autoimmune disorders. AnteoTech’s products are designed to be used in clinical settings and research labs. The company’s objective is to improve the accuracy and efficiency of diagnostics tests, while minimizing the cost and time it takes to deliver results.